Glial Fibrillary Acidic Protein (GFAP) Peptide
GFAP
Reactivité: Humain, Boeuf (Vache), Singe, Mouton
Hôte: Synthetic
BP
-
- Antigène Tous les produits GFAP
- GFAP (Glial Fibrillary Acidic Protein (GFAP))
- Origine
- Humain, Boeuf (Vache), Singe, Mouton
-
Source
- Synthetic
- Application
- Blocking Peptide (BP)
- Attributs du produit
- The peptide is used to block Anti-GFAP Antibody reactivity.
-
Glial Fibrillary Acidic Protein (GFAP) peptide
GFAP Reactivité: Humain, Souris, Rat, Chien Hôte: Synthetic BP, Imm
-
- Indications d'application
- Blocking Peptide to the diluted primary antibody in a molar ratio of 10:1 (peptide to antibody) and incubate the mixture at 4 °C for overnight or at room temperature for 2 hours.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Stock
- -20 °C
- Stockage commentaire
- Shipped at 4°C. Store at -20°C for one year.
- Date de péremption
- 12 months
-
- Antigène
- GFAP (Glial Fibrillary Acidic Protein (GFAP))
- Synonymes
- GFAP Peptide, AI836096 Peptide, cb345 Peptide, etID36982.3 Peptide, gfapl Peptide, wu:fb34h11 Peptide, wu:fk42c12 Peptide, xx:af506734 Peptide, zgc:110485 Peptide, glial fibrillary acidic protein Peptide, GFAP Peptide, LOC100136168 Peptide, gfap Peptide, Gfap Peptide
- Sujet
- Glial fibrillary acidic protein, GFAP
- ID gène
- 2670
- UniProt
- P14136
-
Vous êtes ici:
